| Patient | Satchel Paige |
|---|---|
| Date of birth | 1906-07-07 |
| Identifiers | MRN HR-ML047-SYN-TD; SSN (made up) 000-47-3381 |
| Document date | 1979-07-14 |
| Author | Delphine Whitaker-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing primary care for two years of breathlessness on exertion and a morning cough: history, examination, blood tests including alpha-1 antitrypsin and eosinophils, ECG, NT-proBNP, cardiovascular risk, vaccines, a reliever inhaler and a pulmonology consultation. [S]
Hemoglobin: 15.2 g/dL; White blood cells: 7.1 10*3/uL; Eosinophils (absolute): 0.08 10*3/uL; Alpha-1 antitrypsin: 142 mg/dL; Sodium: 140 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 1.08 mg/dL; eGFR (CKD-EPI 1974, race-free): 71 mL/min/1.73 m²; Glucose: 96 mg/dL; HbA1c: 5.6%; ALT: 21 U/L; Total cholesterol: 224 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol (calculated): 148 mg/dL (high); Triglycerides: 160 mg/dL (high); NT-proBNP: 92 pg/mL; PHQ-9: 5; AUDIT-C: 1. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1979-07-14 | Body height | 191 | cm | S |
| 1979-07-14 | Body weight | 82.6 | kg | S |
| 1979-07-14 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 1979-07-14 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1979-07-14 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1979-07-14 | Heart rate | 84 | /min | S |
| 1979-07-14 | Respiratory rate | 18 | /min | S |
| 1979-07-14 | Body temperature | 36.7 | Cel | S |
| 1979-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1979-07-14 | Hemoglobin [Mass/volume] in Blood | 15.2 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1979-07-14 | Leukocytes [#/volume] in Blood by Automated count | 7.1 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1979-07-14 | Eosinophils [#/volume] in Blood by Automated count | 0.08 | 10*3/uL | For COPD treatment decisions: below 0.10 argues against an inhaled corticosteroid; 0.30 or more favors one | Normal | S |
| 1979-07-14 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma | 142 | mg/dL | 90-200 mg/dL | Normal | S |
| 1979-07-14 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-146 mmol/L | Normal | S |
| 1979-07-14 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1979-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1979-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1974)/1.73 sq M | 71 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1979-07-14 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 65-99 mg/dL | Normal | S |
| 1979-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 1979-07-14 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 21 | U/L | 9-46 U/L | Normal | S |
| 1979-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 224 | mg/dL | <=199 mg/dL | High | S |
| 1979-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 44 | mg/dL | >=40 mg/dL | Normal | S |
| 1979-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 148 | mg/dL | <=99 mg/dL | High | S |
| 1979-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=149 mg/dL | High | S |
| 1979-07-14 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 92 | pg/mL | Below 125 pg/mL makes heart failure unlikely in an outpatient | Normal | S |
| 1979-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 1979-07-14 | Total score [AUDIT-C] | 1 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 micrograms per inhalation metered-dose inhaler with a spacer, two inhalations every four hours as needed for breathlessness | Two inhalations with a spacer every 4 hours as needed | Respiratory tract route | 1979-07-14 | active | S |
| Atorvastatin 20 mg tablet once a day | One tablet each evening | Oral route | 1979-07-14 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Breathlessness on exertion for about two years, now after one flight of stairs or a block on the level (mMRC 2), with a morning cough and a little clear sputum most days; no chest pain, ankle swelling, orthopnea, wheeze at rest or weight loss; a former smoker of about 30 pack-years; cause under evaluation with spirometry and a pulmonology consultation | active | confirmed | R06.09 | S — Synthetic presenting problem anchored to his documented emphysema; superseded when spirometry at the consultation confirmed COPD. |
| Former cigarette smoker, about 30 pack-years, stopped eleven years ago on his own; no use since | active | confirmed | Z87.891 | S — Synthetic smoking history: whether he smoked is not documented in the sources read, so the history is synthetic and labeled as such. |
| Hyperlipidemia: LDL 148 mg/dL, HDL 44 and triglycerides 160 at intake; estimated 10-year cardiovascular risk about 18 percent; atorvastatin started by shared decision | active | confirmed | E78.5 | S — Synthetic cardiovascular risk factor anchored to his documented heart trouble; not a claim about his real lipids. |